Suppr超能文献

肠道微生物群是肥胖和2型糖尿病的一个风险因素。

[Gut microbiota is a factor of risk for obesity and type 2 diabetes].

作者信息

Demidova T Y, Lobanova K G, Oinotkinova O S

机构信息

Pirogov Russian National Research Medical University.

Lomonosov Moscow State University.

出版信息

Ter Arkh. 2020 Nov 24;92(10):97-104. doi: 10.26442/00403660.2020.10.000778.

Abstract

Gut microbiota (GM) is a set of bacteria which colonize the gastrointestinal tract. GM and its active metabolites take part in intestinal and hepatic gluconeogenesis, in the synthesis of incretin hormones, and affect the regulation of appetite. Thus, GM and its metabolites participate in the homeostasis of carbohydrates and fats. An imbalance in the set of the intestinal flora and a disturbance of the production of active metabolites sharply increases the risk of developing obesity and type 2 diabetes. There are conflicting data in the literature on the role of specific microorganisms in the development of metabolic disorders. Research is needed to identify specific types of bacteria and their active metabolites which affect the development of obesity and type 2 diabetes.

摘要

肠道微生物群(GM)是一组定植于胃肠道的细菌。GM及其活性代谢产物参与肠道和肝脏的糖异生、肠促胰岛素激素的合成,并影响食欲调节。因此,GM及其代谢产物参与碳水化合物和脂肪的稳态。肠道菌群组成失衡以及活性代谢产物产生紊乱会大幅增加肥胖和2型糖尿病的发病风险。关于特定微生物在代谢紊乱发展中的作用,文献中的数据相互矛盾。需要开展研究以确定影响肥胖和2型糖尿病发展的特定细菌类型及其活性代谢产物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验